-
1دورية أكاديمية
المؤلفون: Umeshappa CS; 1 Cancer Research Unit, Saskatchewan Cancer Agency, University of Saskatchewan , Saskatoon, Canada ., Zhu Y, Bhanumathy KK, Omabe M, Chibbar R, Xiang J
المصدر: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2015 Mar; Vol. 30 (2), pp. 72-8. Date of Electronic Publication: 2015 Feb 25.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE
مواضيع طبية MeSH: Adaptive Immunity/*immunology , Immunity, Innate/*immunology , Lung Neoplasms/*immunology , Melanoma, Experimental/*immunology , Neoplasm Metastasis/*immunology, Animals ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cell Line, Tumor ; Dendritic Cells/immunology ; Killer Cells, Natural/immunology ; Lung Neoplasms/pathology ; Melanoma, Experimental/pathology ; Mice ; Mice, Inbred C57BL ; T-Lymphocytes, Cytotoxic/immunology
-
2دورية أكاديمية
المؤلفون: Yan S; Department of Radiation Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou, People's Republic of China. yansenxiang@zju.edu.cn, Jiang X, Yang J, Yan D, Wang YX
المصدر: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2012 Oct; Vol. 27 (8), pp. 519-23. Date of Electronic Publication: 2012 Jul 26.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE
مواضيع طبية MeSH: Liver Transplantation*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lung Neoplasms/*drug therapy , Lung Neoplasms/*secondary , Nasopharyngeal Neoplasms/*radiotherapy, Antibodies, Monoclonal, Humanized/administration & dosage ; Capecitabine ; Carcinoma ; Carcinoma, Hepatocellular/surgery ; Combined Modality Therapy ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Fluorouracil/administration & dosage ; Fluorouracil/analogs & derivatives ; Humans ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/pathology ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated
-
3دورية أكاديمية
المؤلفون: Xie Y; Cell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China., Sheng W, Xiang J, Ye Z, Zhu Y, Chen X, Yang J
المصدر: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2008 Jun; Vol. 23 (3), pp. 310-20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE
مواضيع طبية MeSH: Apoptosis* , Neovascularization, Pathologic*, Carcinoma/*drug therapy , Interleukins/*therapeutic use , Lung Neoplasms/*drug therapy , Recombinant Proteins/*therapeutic use, Animals ; Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; Cell Proliferation ; Chick Embryo ; Humans ; Leukocytes, Mononuclear/cytology ; Leukocytes, Mononuclear/metabolism ; Lipopolysaccharides/metabolism ; Mice